Cantor Fitzgerald Reiterates Overweight on Merck & Co, Maintains $155 Price Target
Merck & Co Analyst Ratings
Cantor Fitzgerald Reiterates Overweight on Merck & Co, Maintains $155 Price Target
HSBC Adjusts Price Target on Merck & Co. to $130 From $118, Keeps Hold Rating
Merck & Co Analyst Ratings
Cantor Fitzgerald Reiterates Overweight on Merck & Co, Maintains $155 Price Target
Redburn Atlantic Adjusts Price Target on Merck to $148 From $142
Major Bank Ratings | Damo: Raising Merck's Target Price to $132, Keytruda Continues Strong Growth
Major Bank Ratings | Goldman Sachs: Raising Merck's Target Price to $144, Rating “Buy”
Merck & Co Analyst Ratings
Jefferies Adjusts Merck & Company Price Target to $150 From $145
Cantor Fitzgerald Adjusts Merck & Co.' Price Target to $155 From $135, Keeps Overweight Rating
Cantor Fitzgerald Corp.: The Merck & Co (MRK.US) rating was reaffirmed and adjusted from an increase to an increase in holdings rating, with a target price of $135.00.
Merck & Co Analyst Ratings
Cantor Fitzgerald Reiterates Overweight on Merck & Co, Maintains $135 Price Target
Berenberg: Maintaining the Merck & Co (MRK.US) rating, adjusted from buy to buy rating, and the target price was adjusted from $140.00 to $143.00.
Merck & Co Analyst Ratings
Berenberg Maintains Buy on Merck & Co, Raises Price Target to $143
Merck & Company (MRK) Receives a Buy From Cantor Fitzgerald
Merck & Co Analyst Ratings